CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy.

Saved in:
Bibliographic Details
Title: CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy.
Authors: Stringer-Reasor E; 1O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL., Li Y; 1O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL., Zhang J; 1O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL., Rocque G; 1O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL., Jones K; 2Tuskegee University, Tuskegee, AL., O'Sullivan C; 3Mayo Clinic Comprehensive Cancer Center, Rochester, MN., Giridhar K; 3Mayo Clinic Comprehensive Cancer Center, Rochester, MN., Dees EC; 4University of North Carolina, Chapel Hill, NC., Nanda R; 5University of Chicago, Chicago, IL., Hunter N; 6University of Washington, Seattle, WA., Clark A; 7University of Pennsylvania, Philadelphia, PA., Wolff A; 8The Sidney Kimmel Comprehensive Cancer Center at John's Hopkins University, Baltimore, MD., Krop I; 9Smillow Cancer Hospital, Yale University, New Haven, CT., Lin N; 10Dana-Farber Cancer Institute, Boston, MA., Rimawi MF; 11Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Yang ES; 12Markey Cancer Center, University of Kentucky, Lexington, KY.
Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Mar 31; Vol. 24 (3.5). Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1540-1413
DOI:10.6004/jnccn.2025.7190